GENETIC MARKERS OF NEGATIVE OUTCOMES OF THE ACUTE CORONARY SYNDROME
https://doi.org/10.15829/1560-4071-2014-10-19-22
Abstract
Aim. To evaluate the relationship of 8 mononucleotide polymorphisms (MNP) with negative longterm prognosis of the acute coronary syndrome.
Material and methods. Totally 280 patients with acute coronary syndrome included (ACS), who during 1 year follow up were underwent the solid endpoints evaluation (cardiovascular death, hospitalization for recurrent ischemic event and repeated revascularization).
Results. In the analysis of rs4804611 in group with negative outcomes there is significantly more prevalent genotype GG (9,1% vs. 1,8%), chances relation 5,57 (95% CI 1,35-22,96); credibility of the differences kept in men (p=0,021). In the analysis rs2549513 in the group with positive prognosis the AA genotype was more prevalent (70,6% vs. 53%), hazard ratio 0,47 (95% CI 0,26-0,85), and in the group with negative prognosis genotype AC, chances relation 2,32 (95% CI 1,28-4,20; р=0,007).
While separated by gender credible differences were shown only in men (p=0,008).
Conclusion. Evaluation of genetic markers rs4804611 and rs2549513 can significantly increase prognostic value in riskometry of ACS outcomes.
About the Authors
N. G. LozhkinaRussian Federation
V. N. Maksimov
Russian Federation
P. S. Orlov
Russian Federation
Kuimov A. D.
Russian Federation
M. I. Voevoda
Russian Federation
References
1. Bluzhas I, Buivydaite K, Domarkiene S, et al. Dynamics of acute myocardial infarction morbidity and risk of acute ischemic syndrome among population of Kaunas in 1986—2001. Kardiologiia 2006; 46(4):52—3. Russian (Блужас И., Буйвидайте К., Домаркене С. и др. Динамика заболеваемости острым инфарктом миокарда и риска острого коронарного синдрома среди населения Каунаса в 1986—2001 гг. Kaрдиология 2006; 46(4):52—53).
2. Raposeiras-Roubín S, Abu-Assi E, Cabanas-Grandio P, et al. Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome: what do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and GWTG [Get With the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart Risk Scores Provide? JACC Cardiovasc Interv 2012; Nov; 5(11):1117—25.
3. Carmo P, Ferreiro J, Aguiar C, et al. Does continuous ST-segment monitoring add prognostic information to the TIMI, PURSUIT, and GRACE risk scores? Ann Noninvasive Electrocardiol 2011; Jul; 16(3):239—49.
4. Damman P,Woudstra P, Kuijt WJ, et al. Short and long-term prognostic value of the TIMIrisk score after primary percutaneous coronary intervention for STsegment elevation myocardial infarction. J Interv Cardiol 2013; Feb;26(1):8—13.
5. Schnur S. Mortality rates in acute myocardial infarction. The normal yearly variation, and the effect of hospital admission policy. Ann Intern Med 1953; Nov; 39(5):1014—7.
6. Fuente RL, Naesgaard PA, Nilsen ST, et al. B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, Argentina. BMC Cardiovasc Disord 2011; 11: 57.
7. López-Cuenca A, Manzano-Fernandtz S, Lip GY, et al. Interleukin-6 and High-sensitivity C-reactive Protein for the Prediction of Outcomes in non ST Segment Elevation Acute Coronary Syndromes. Rev Esp Cardiol 2012; Dec. 7.
8. Wauters E, Carruthers KF, Buysschaert I, et al. Influence of 23 coronary artery disease variants on recurrent myocardial infarction or cardiac death: the GRACE Genetics Study Eur Heart J 2013; Apr;34(13):993—1001.
9. Ozkan B, Cagliyan CE, Elbasan Z, et al. PAI-1 4G/5G gene polymorphism is associated with angiographic patency in ST-elevation myocardial infarction patients treated with thrombolytic therapy. Coron Artery Dis 2012; Sep;23(6):400—3.
10. Sukhinina TS, Shakhnovich RM, Barsova RM, et al. Value of allele gene polymorphism of the inflammation system for prognosis of patients with myocardial infarction. Kardiologiia 2012; 52(3):15—21. Russian (Сухинина Т. С., Шахнович Р. М., Барсова Р. М. и др. Значение аллеля полиморфизма гена системы воспаления для прогноза больных инфарктом миокарда. Кардиология 2012, 52(3):15—21).
11. Virani SS, Brautbar A, Lee VV, et al. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J 2012; 76(4):950—6.
12. Marchegiani F, Spazzafumo L, Provinciali M, et al. Paraoxonase2 C311S polymorphism and low levels of HDL contribute to a higher mortality risk after acutemyocardial infarction in elderly patients. Mol Genet Metab 2009; Nov;98(3):314—8.
13. Sibbing D, von Beckerath O, von Beckerath N, et al. Plasminogen activator inhibitor-1 4G/5G polymorphism and efficacy of reperfusion therapy in acute myocardial infarction. Blood Coagul Fibrinolysis 2005; Oct;16(7):511—5.
14. Maksimov VN, Kulikov IV, Orlov PS, et al. Checking the relationship between the eight SNPs and myocardial infarction in the Siberian population. Bulletin of the Russian Academy of Medical Scientists 2012; 5: 24—29). Russian (Максимов В. Н., Куликов И. В., Орлов П. С. и др. Проверка взаимосвязи между восемью однонуклеотидными полиморфизмами и инфарктом миокарда на сибирской популяции. Вестник Российской академии медицинских ученых 2012; 5: 24—29).
Review
For citations:
Lozhkina N.G., Maksimov V.N., Orlov P.S., D. K.A., Voevoda M.I. GENETIC MARKERS OF NEGATIVE OUTCOMES OF THE ACUTE CORONARY SYNDROME. Russian Journal of Cardiology. 2014;(10):19-22. (In Russ.) https://doi.org/10.15829/1560-4071-2014-10-19-22